This episode discusses the Child-Pugh scale to assess hepatic impairment. It also covers the FDA's position on the inclusion of drug metabolism data for various Child-Pugh stages and cirrhosis.

Faculty: Jonathan Meyer, M.D. Hosts: Jessica Diaz, M.D.; Flavio Guzman, M.D.

• Learn more about our memberships here
• Earn 1 CME: Use of Psychotropics in Patients With Hepatic Issues
• The Importance of Child-Pugh Classification for Staging Hepatic Impairment